Radius Health

167 articles with Radius Health

• Radius Health Announces Publication Of Additional Positive Results From The Phase 3 ACTIVE Trial Of Abaloparatide-SC In JBMR

  9/19/2016

• Radius Health Announces Three Presentations On RAD1901 At The San Antonio Breast Cancer Symposium (SABCS) December 6-10, 2016

  8/30/2016

• 3 High-Risk, High-Reward Biotech Stocks

  8/25/2016

• Radius Health Release: JAMA Publishes Positive Phase 3 Data For Abaloparatide In Postmenopausal Women With Osteoporosis

  8/16/2016

• Radius Health May Be Acquisition Target for Shire Based on Its Osteoporosis Pipeline

  8/12/2016

• Radius Health Reports Second Quarter 2016 Financial And Operating Results

  8/4/2016

• Radius Health To Present At The 36th Annual Canaccord Genuity Growth Conference

  8/3/2016

• 3 Biotech Stocks That Could Explode in the Next 12 Months

  7/22/2016

• Radius Health Announces Multiple Presentations At The American Society For Bone And Mineral Research 2016 Annual Meeting September 16-19, 2016

  7/21/2016

• Radius Health To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference

  7/5/2016

• Massachusetts-Based Radius Health Opens Up Shop in Philadelphia with Plans to Hire 100+ Employees

  6/23/2016

• Editas Medicine And Radius Health Choose Mass Innovation Labs For Rapid Start And Operational Capabilities

  5/4/2016

• Editas Medicine And Radius Health Choose Mass Innovation Labs For Rapid Start And Operational Capabilities

  5/3/2016

• 10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015

  3/24/2016

• Five Companies Face Big FDA Decisions This Month

  3/14/2016

• Radius Health To Present At The Cowen and Company 36th Annual Health Care Conference

  3/1/2016

• Radius Health Appoints Former GlaxoSmithKline CEO Jean-Pierre Garnier To Board Of Directors

  12/8/2015

• Radius Health Announces Conference Call And Webcast On New Data For Investigational Drug RAD1901 To Be Presented At San Antonio Breast Cancer Symposium 2015

  12/7/2015

• Radius Health Delays Osteoporosis Drug Application in the U.S. to Avoid Rush, Respect Staffers' Holidays

  11/18/2015

• Radius Health Has Submitted A Marketing Authorization Application For The Investigational Drug Abaloparatide-SC For The Treatment Of Postmenopausal Osteoporosis In Europe

  11/17/2015